RNA editing promises to go where DNA editing can’t
On October 16, a biotechnology company in Massachusetts in the U.S. named Wave Life Sciences made headlines for becoming the first company to treat a genetic condition by editing RNA at the clinical level. But for all that this is a breakthrough, scientists had anticipated it. The role of RNA in a function called RNA … Read more